Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking

Ilie M , Hofman V , Dietel M , Soria JC , Hofman P . Assessment of the PD-L1 status by immunohistochemistry: Challenges and perspectives for therapeutic strategies in lung cancer patients. Virchows Arch, 2016; 468:511–525.

Bernini P , Bertini I , Luchinat C , Nincheri P , Staderini S , Turano P . Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR, 2011; 49:231–243.

Gundisch S , Hauck S , Sarioglu H , et al. Variability of protein and phosphoprotein levels in clinical tissue specimens during the preanalytical phase. J Proteome Res, 2012; 11:5748–5762.

Gundisch S , Grundner-Culemann K , Wolff C , et al. Delayed times to tissue fixation result in unpredictable global phosphoproteome changes. J Proteome Res, 2013; 12:4424–4434.

Moore HM , Kelly AB , Jewell SD , et al. Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol, 2011; 119:92–101.

Simeon-Dubach D , Watson P . Biobanking 3.0: Evidence based and customer focused biobanking. Clin Biochem, 2014; 47:300–308.

Watson PH , Nussbeck SY , Carter C , et al. A framework for biobank sustainability. Biopreserv Biobank, 2014; 12:60–68.

Clement B , Yuille M , Zaltoukal K , et al. Public biobanks: Calculation and recovery of costs. Sci Transl Med, 2014; 6:261fs45.

Vaught J , Rogers J , Carolin T , Compton C . Biobankonomics: Developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr, 2011; 2011:24–31.

Hofman P , Brechot C , Zatloukal K , Dagher G , Clement B . Public-private relationships in biobanking: A still underestimated key component of open innovation. Virchows Arch, 2014; 464:3–9.

Bjorkman J , Svec D , Lott E , Kubista M , Sjoback R . Differential amplicons (DeltaAmp)-a new molecular method to assess RNA integrity. Biomol Detect Quantif, 2016; 6:4–12.

Bonin S , Stanta G . Nucleic acid extraction methods from fixed and paraffin-embedded tissues in cancer diagnostics. Expert Rev Mol Diagn, 2013; 13:271–282.

Schulz KF , Altman DG , Moher D ; CONSORT Group. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. Ann Intern Med, 2010; 152:726–732.

McShane LM , Altman DG , Sauerbrei W , et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer, 2005; 93:387–391.

Bossuyt PM , Reitsma JB , Bruns DE , et al. The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration. Clin Chem, 2003; 49:7–18.

von Elm E , Altman DG , Egger M , et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Med, 2007; 4:e296.

Lehmann S , Guadagni F , Moore H , et al. Standard preanalytical coding for biospecimens: Review and implementation of the Sample PREanalytical Code (SPREC). Biopreserv Biobank, 2012; 10:366–374.

Lazar AN , Bich C , Panchal M , et al. Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients. Acta Neuropathol, 2013; 125:133–144.

Chung K , Deisseroth K . CLARITY for mapping the nervous system. Nat Methods, 2013; 10:508–513.

Chung K , Wallace J , Kim SY , et al. Structural and molecular interrogation of intact biological systems. Nature, 2013; 497:332–337.

Ando K , Laborde Q , Lazar A , et al. Inside Alzheimer brain with CLARITY: Senile plaques, neurofibrillary tangles and axons in 3-D. Acta Neuropathol, 2014; 128:457–459.

Ruan L , Song Y , Fan J , Ying H , Gan R . The Shanghai biobanking DNA quality control program. Biopreserv Biobank, 2014; 12:259–264.

Contamination of cell lines—A conspiracy of silence. Lancet Oncol, 2001; 2:393.

Coecke S , Balls M , Bowe G , et al. Guidance on good cell culture practice. A report of the second ECVAM task force on good cell culture practice. Altern Lab Anim, 2005; 33:261–287.

Geraghty RJ , Capes-Davis A , Davis JM , et al. Guidelines for the use of cell lines in biomedical research. Br J Cancer, 2014; 111:1021–1046.

Cacciatore S , Hu X , Viertler C , et al. Effects of intra- and post-operative ischemia on the metabolic profile of clinical liver tissue specimens monitored by NMR. J Proteome Res, 2013; 12:5723–5729.

Want EJ , Wilson ID , Gika H , et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc, 2010; 5:1005–1018.

Chan EC , Pasikanti KK , Nicholson JK . Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry. Nat Protoc, 2011; 6:1483–1499.

Dunn WB , Broadhurst D , Begley P , et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc, 2011; 6:1060–1083.

Vaught J , Abayomi A , Peakman T , Watson P , Matzke L , Moore H . Critical issues in international biobanking. Clin Chem, 2014; 60:1368–1374.

Ellervik C , Vaught J . Preanalytical variables affecting the integrity of human biospecimens in biobanking. Clin Chem, 2015; 61:914–934.